Hikma buys rights to FDA-approved cancer treatment trametinib, a generic version of Novartis' (NVS) Mekinist, with 180 days ...

Many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs. A doctor ...

People diagnosed with type 2 diabetes might benefit soon from Eli Lilly's new orforglipron weight loss drug following its ...

Life-brand melatonin tablets are being recalled because they have the wrong dosing instructions on the label. The recall, published by Health Canada, did not specify what the incorrect ...

Do you know which goods you should always buy generic instead of opting for the name brands? You might be surprised by some ...

Patients on the new pill also lost weight — up to 16 pounds without reaching a plateau at the study’s end. Side effects were ...

Tariffs could stall drug manufacturing in the US, increase reliance on China Reliance on China for medicines and ingredients has been a concern for both Democratic and Republican lawmakers for ...

the bioequivalent of Astellas' overactive bladder drug, Myrbetriq, in the United States. According to the judgment, the Delaware District Court upheld the validity of Astellas Pharma’s Patent ...

Therefore, even if the estimated $150-300 million in FY25 revenue from the drug is lost, the brokerage firm's target prices, based on FY27 estimates, remain largely unchanged. However, Elara ...

Novo Nordisk submitted an oral version of the weight-loss formulation of semaglutide (Wegovy) for FDA approval, according to ...

Medication affordability is a prevalent issue: according to a study from West Health and Gallup, an estimated 15.5 million adults under 65 went without medication due to high drug costs.